Skip to main content
letter
. 2023 Jan 23;11(1):e01179-22. doi: 10.1128/spectrum.01179-22

TABLE 1.

Sample, infection type, matrix-assisted laser desorption ionization–time of flight mass spectrometry identification, and sample collection datea

Isolate Patient Collection date City of isolation Clinical sample Infection type MALDI ID Presence of mecA, lukS-lukF genes Susceptibility (S) or resistance (R)
S R
01SAP 1 06/19/2019 São Paulo Mastitis secretion HAI S. argenteus/S. schweitzeri Negative FOX, CIPO, CLIN, ERY, GEN, LZD, PEN, TET, SXT, VAN
02SAP 2 12/12/2018 São Paulo Blood CAI S. argenteus Negative FOX, CIPO, CLIN, ERY, GEN, LZD, TET, SXT, VAN PEN
07SAP 2 12/12/2018 São Paulo Skin abscess CAI S. argenteus Negative FOX, CIPO, CLIN, ERY, GEN, LZD, PEN, TET, SXT, VAN
01POA 3 05/06/2019 Porto Alegre Umbilical cord HAI S. schweitzeri Negative FOX, CIPO, CLIN, ERY, GEN, LZD, SXT, VAN PEN, TET
02POA 4 05/27/2019 Porto Alegre Blood HAI S. argenteus Negative FOX, CIPO, CLIN, ERY, GEN, LZD, PEN, TET, SXT, VAN
a

MALDI ID, matrix-assisted laser desorption ionization–time of flight mass spectrometry identification; HAI, Healthcare-associated infection; CAI, Community-acquired infection; FOX, cefoxitin; CIP, ciprofloxacin; CLIN, clindamycin; ERY, erythromycin; GEN, gentamicin; LZD, linezolid; PEN, penicillin; TET, tetracycline; SXT, trimethoprim-sulfamethoxazole; VAN, vancomycin.